A U.K. study of hydroxychloroquine found no benefit for patients already sick with COVID-19. Treatment with the malaria drug didn’t help hospitalized patients survive or recover faster any more than standard treatment, according to the large study. (BioPharma Dive)
Singapore to give all residents a wearable contact tracing device to track coronavirus. The device would be given to each of its 5.7 million residents. It could help identify people who has interacted with carriers of coronavirus. (Reuters)
AbbVie has partnered with three organizations to develop COVID-19 antibody. AbbVie, Netherlands’ Utrecht University, biotech Harbour BioMed and Erasmus Medical Center are working together on the project to develop a preventive therapy for the illness. (Reuters)
Americans are incorrectly using cleaning products due to coronavirus, according to a survey from the Centers for Disease Control and Prevention. Some are cleaning food, their skin or even gargling with bleach or other disinfectants to try to kill coronavirus, leading to other health issues. (STAT)
Sun Pharmaceuticals began a trial of a plant-based coronavirus treatment. The trial is testing a drug originally developed for dengue that has also shown promise in treating coronaviruses. Results from the phase 2 trial are expected in October. (Bloomberg)
